The role of ketoconazole in current prostate cancer care.

Nature Reviews. Urology
Vaibhav PatelWilliam Oh

Abstract

Ketoconazole is a nonselective steroid 17α-hydroxylase/17,20 lyase (CYP17A1) inhibitor that has been used, off-label, as a second-line therapy for castration-resistant prostate cancer (CRPC). The drug has shown clinical efficacy without survival benefit. Despite not improving survival, ketoconazole has beneficial characteristics, such as its low cost, a relatively favourable toxicity profile compared with chemotherapy, and its efficacy both before and after chemotherapy. The approval of several new, highly effective treatments, including abiraterone acetate, enzalutamide, and apalutamide, warrants re-evaluation of the role of ketoconazole and other classic agents in achieving the optimal timing and sequencing of available agents to prolong survival and maintain patients' quality of life. In the current CRPC treatment landscape, we believe that ketoconazole can be considered in patients with nonmetastatic CRPC and in those with metastatic CRPC who do not respond to, tolerate, or have access to chemotherapy and other standard therapeutic options.

References

Aug 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L TrumpV C Jordan
Sep 24, 1987·The New England Journal of Medicine·N Sonino
Aug 25, 1984·Lancet·J Trachtenberg, A Pont
Jun 1, 1981·Antimicrobial Agents and Chemotherapy·R DeFeliceJ N Galgiani
Sep 1, 1982·Annals of Internal Medicine·A PontD A Stevens
Oct 1, 1983·The Journal of Clinical Endocrinology and Metabolism·R J SantenR DeCoster
Aug 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H I Scher, W K Kelly
Sep 1, 1994·The Journal of Steroid Biochemistry and Molecular Biology·S E BarrieM Jarman
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P W KantoffN J Vogelzang
Sep 20, 2001·Investigational New Drugs·R DreicerE A Klein
Aug 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D S ErnstW Parulekar
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric J SmallNicholas J Vogelzang
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Oct 8, 2004·The New England Journal of Medicine·Daniel P PetrylakE David Crawford
Jul 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark A TitusJames L Mohler
Jul 15, 2005·JAMA : the Journal of the American Medical Association·Nima SharifiWilliam L Dahut
Mar 28, 2007·Prostate Cancer and Prostatic Diseases·K SuzukiF Labrie
Apr 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Charles J RyanEric J Small
Apr 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D Andrew LoblawUNKNOWN American Society of Clinical Oncology
Jun 5, 2007·Bioorganic & Medicinal Chemistry·Robert D Bruno, Vincent C O Njar
Jul 16, 2008·Current Opinion in Pharmacology·Timothy A YapJohann S de Bono
Oct 30, 2009·BJU International·Mari NakabayashiJonathan E Rosenberg
Nov 6, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mary-Ellen TaplinSteven P Balk
Feb 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel C DanilaHoward I Scher
Sep 3, 2010·Cancer Research·Meng-Lei ZhuNatasha Kyprianou
Sep 8, 2010·The New England Journal of Medicine·Philip W KantoffUNKNOWN IMPACT Study Investigators
May 27, 2011·The New England Journal of Medicine·Johann S de BonoUNKNOWN COU-AA-301 Investigators

❮ Previous
Next ❯

Citations

Jun 12, 2020·Dalton Transactions : an International Journal of Inorganic Chemistry·Radosław StarostaAnna Krasowska
Aug 28, 2020·Oncotarget·Justyna Magdalena HermanowiczDariusz Pawlak
Nov 9, 2019·Scientific Reports·Rodrigo F M de AlmeidaRadosław Starosta
Aug 4, 2020·The Keio Journal of Medicine·Hideaki NagashimaOltea Sampetrean
Jan 23, 2021·Endocrine Reviews·Kunal DesaiNima Sharifi
May 19, 2021·Nature Reviews. Urology·Soum D LokeshwarFred Saad
Jun 24, 2021·Microbiology Spectrum·Yi XuFeng Yang
Jul 3, 2021·Cancers·Christina PfabNahed El-Najjar

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear translocation

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.